Ignite Creation Date:
2024-05-06 @ 12:56 AM
Last Modification Date:
2024-10-26 @ 10:56 AM
Study NCT ID:
NCT01693471
Status:
COMPLETED
Last Update Posted:
2013-03-01
First Post:
2012-09-21
Brief Title:
Survey on the Effect of Health Related Quality of Life QOL Associated With Compliance of Carbocisteine in Asthma Patients
Sponsor:
Kyorin Pharmaceutical CoLtd
Organization:
Kyorin Pharmaceutical CoLtd
Study Overview
Official Title:
Survey on the Effect of Health Related QOL Associated With Compliance of Carbocisteine in Asthma Patients Study SEARCH Study
Status:
COMPLETED
Status Verified Date:
2013-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objectives of this study are to investigate the influence on HR-QOL SF-36 v2 resulting from the compliance of MUCODYNE Tablets or MUCODYNE DS Dry Syrup 50 in asthma patients whose control levels are partly controlled or uncontrolled
Detailed Description:
Period 2012-2013 Observation Time 0 week 4 week
Matters investigated
1 QOL determination using SF-36 v2
2 Medication compliance VAS scale
3 Gender age diagnosis asthma subtype severity duration of disease level of asthma control concomitant drugs comorbidities smoking alcohol work
Matters investigated
1 QOL determination using SF-36 v2
2 Medication compliance VAS scale
3 Gender age diagnosis asthma subtype severity duration of disease level of asthma control concomitant drugs comorbidities smoking alcohol work
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None